The short version
5 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
pazopanib
pazopanib hydrochloride · PAZOPANIB HYDROCHLORIDE 400 mg/1 · Tablet, Film Coated · Oral · Torrent Pharmaceuticals Limited
NDC 13668-0735-30 · 30 TABLET, FILM COATED in 1 BOTTLE · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Estimated fill cost
WAC per package, as filed
$4,454.66
Reported to Texas DSHS · 2026 annual filing · Torrent Pharmaceuticals
Manufacturer list price as filed — not what pharmacies actually pay after discounts.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Where it's made
- analysis · manufacture · pack
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
Regulatory
- Application
- ANDA219922
- TE code
- —
- Approval date
- Sep 4, 2025
- Patents / exclusivity
- 0 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | CGT | May 6, 2026 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of pazopanib hydrochloride (Tablet, Film Coated)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Glaxo Operations UK Ltd | PAZOPANIB HYDROCHLORIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novartis Pharma Produktions GmbH | PAZOPANIB HYDROCHLORIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novartis Pharmaceuticals Corporation | PAZOPANIB HYDROCHLORIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Novugen Pharma (USA) LLC. | PAZOPANIB HYDROCHLORIDE 200 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| Torrent Pharmaceuticals Limited | PAZOPANIB HYDROCHLORIDE 400 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "pazopanib — NDC 13668-0735-30," retrieved September 3, 2026, https://drugdashboards.com/drug/13668073530.
Free to cite with attribution — see how the data is put together.